Sign In
Get Clay Free →

Suggestions

    Norman Tse, CFA

    Vice President, Healthcare at Unicorn Capital Partners

    I am currently a Vice President (Healthcare) at Unicorn Capital Partners, a leading fund-of-funds platform that focuses on venture capital fund and direct investment opportunities in Asia.

    Previously I was a Vice President at Nan Fung Life Sciences, a global investment platform with US$2B commitment from Nan Fung Group. Prior to that, I managed the global healthcare equity portfolio at Hinrich Foundation and family office of the Founder of Global Sources (acquired by Blackstone for US$400m+).

    I graduated with a master degree in Bioengineering at UC Berkeley and a bachelor degree in Biochemistry at the University of Hong Kong. I completed the CFA program in 2017.

    Related Questions

    What are Norman Tse's main responsibilities at Unicorn Capital Partners?
    How long has Norman Tse been working in the healthcare investment sector?
    What are some notable investments Norman Tse has been involved in at Bluejay Therapeutics?
    What is Norman Tse's educational background?
    How did Norman Tse transition from City University of Hong Kong to Unicorn Capital Partners?
    Norman Tse, CFA
    Norman Tse, CFA, photo 1
    Norman Tse, CFA, photo 2
    Get intro to Norman
    Add to my network

    Experience

    Vice President, Healthcare at Unicorn Capital Partners (June 2022 - Present)
    Panelist (Biotechnology Subgroup) at Innovation and Technology Commission, HKSAR Government (March 2023 - Present), Vice President at Pivotal Life Sciences (January 2021 - June 2022)

    Education

    Master of Translational Medicine, Bioengineering and Biomedical Engineering, University of California, Berkeley and University of California, San Francisco (2013 - 2014) Bachelor of Science (B.Sc.), Biochemistry, The University of Hong Kong (2010 - 2013)

    Location

    Hong Kong SAR